发明名称 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
摘要 The compounds of formula (1.0) are inhibitors of the enzyme, farnesyl protein transferase, and may be used to inhibit the abnormal growth of cells in humans. In formula (1.0): one of a, b, c and d represents N or NR9, wherein R9 is O, CH3 or (CH2)nCO2H wherein n is 1 to 3, and the remaining a, b, c and d groups represent CR1 or CR2; or each of a, b, c and d are independently selected from CR1 or CR2; R1 and R2 are independently selected from H, halo, CF3, OR10, COR10, SR10, S(O)tR11 (wherein t is 0, 1 or 2), SCN, N(R10)2, NR10R11, NO2, OC(O)R10, CO2R10, OCO2R11, CN, NHC(O)R10, NHSO2R10, CONHR10, CONHCH2CH2OH, NR10COOR11, SR11C(O)OR11, SR11N(R75)2; wherein each R75 is independently selected from H and C(O)OR11, benzotriazol-1-yloxy, tetrazol-5-ylthio, or substituted tetrazol-5-ylthio, alkynyl, alkenyl or alkyl, said alkyl or alkenyl group optionally being substituted with halo, OR10 or CO2R10; R3 and R4 are the same or different selected from H, any of the substituents of R1 and R2; or R3 and R4 taken together represent a saturated or unsaturated C5-C7 fused ring, to ring III; R5 and R6 (y=0) or R5, R6 and R7 (y=1) each independently represents H, CF3, COR10, alkyl or aryl, said alkyl or aryl optionally being substituted with OR10, SR10, S(O)tR11, NR10COOR11, N(R10)2, NO2, COR10, OCOR10, OCO2R11, CO2R10, OPO3R10; or one of R5, R6 and R7 can be taken in combination with R40 as defined below to represent (CH2)r wherein r is 1 to 4 which can be substituted with lower alkyl, lower alkoxy, CF3 or aryl; or R5 is combined with R6 or R7 to represent =0 or =S; R10 independently represents H, alkyl, cycloalkyl, cycloalkylalkyl, heteroaryl, aryl, aralkyl or NR40R42 wherein R40 and R42 independently represent H, aryl, alkyl, aralkyl, heteroaryl, heteroarylalkyl, heterocycloalkyl, heterocycloalkylalkyl, heteroalkyl, cycloalkyl, cycloalkylalkyl, alkenyl and alkynyl; R11 represents alkyl or aryl; the dotted line represents an optional double bond, such that when a double bond is present, A and B independently represent NO2, R10, halo, OR11, OCO2R11 or OC(O)R10; and when no double bond is present between carbon atoms 5 and 6, A and B each independently represent H2, (OR11)2, H and halo, dihalo, alkyl and H, (alkyl)2, H and OC(O)R10, H and OR10, oxy, aryl and H, =NOR10 or O-(CH2)p-O wherein p is 2, 3 or 4; y is 0 or 1; n is 0 to 6; T is CO; SO; SO2; or CR30R31 wherein R30 and R31 independently represent H, alkyl, aryl, aralkyl, heteroalkyl, heteroaryl, heteroarylalkyl, heterocycloalkyl or heterocycloalkylalkyl; and Z represents alkyl, aryl, aralkyl, heteroalkyl, heteroaryl, heteroarylalkyl, heterocycloalkyl, heterocycloalkylalkyl, OR40, SR40, CR40R42, NR40R42, or other group depicted above.
申请公布号 NZ334341(A) 申请公布日期 2001.01.26
申请号 NZ19970334341 申请日期 1997.09.11
申请人 SCHERING CORPORATION 发明人 RANE, DINANATH F;COOPER, ALAN B;MALLAMS, ALAN K;DOLL, RONALD J;NJOROGE, F GEORGE;TAVERAS, ARTHUR G
分类号 A61K31/4545;A61P35/00;C07D401/14;(IPC1-7):A61K31/444 主分类号 A61K31/4545
代理机构 代理人
主权项
地址